AI voice biomarker platform identifying signs of depression and anxiety in real time.
What it does
Analyzes 20-second clips of free-form speech to generate real-time depression and anxiety risk scores.
Integrates via REST API with clinical EHR systems, telehealth portals, and call center software.
Provides non-contextual vocal analysis that measures acoustic properties rather than spoken language or keywords.
Delivers objective behavioral health metrics to triage high-risk patients for targeted clinical intervention.
Why it works
Language-agnostic acoustic analysis detects vocal micro-patterns regardless of primary dialect or topic.
API-first design seamlessly embeds mental health screening directly into existing clinical software workflows.
Objective voice biomarkers eliminate manual screening questionnaire bias and reduce patient drop-off.
Proprietary dataset gathered across global users ensures diverse ML model validation and accuracy.
AI voice biomarker platform identifying signs of depression and anxiety in real time.
Overview
Kintsugi is an AI-powered healthcare platform that analyzes voice biomarkers to screen for clinical depression and anxiety from short clips of natural speech. Built for healthcare providers, payors, telehealth vendors, and call centers, the platform detects early signs of mental health conditions regardless of native language or spoken context. By embedding directly into patient intake and call center workflows via API, Kintsugi supplies objective behavioral health data. This enables clinical teams to escalate care and route patients to appropriate interventions.
Founded year:2019
Founder:Grace Chang, Rima Seiilova-Olson
Team size:11-25
Popularity:Raised $28M in funding from tier-one investors and holds multiple National Science Foundation awards.
HQ:Berkeley, California, United States
Status:Active
Funding status:Funded
Customer type:B2B
Funding:$28M
Pricing:Enterprise
Tech stack:Python, PyTorch, TensorFlow, React, FastAPI, AWS, Docker, Signal Processing
Platform:Web • iOS • Android
Integrations:Pegasystems, REST API, Webhooks
What it does
Analyzes 20-second clips of free-form speech to generate real-time depression and anxiety risk scores.
Integrates via REST API with clinical EHR systems, telehealth portals, and call center software.
Provides non-contextual vocal analysis that measures acoustic properties rather than spoken language or keywords.
Delivers objective behavioral health metrics to triage high-risk patients for targeted clinical intervention.
Who it's for
Healthcare Insurance Payors & Health Plans
Telehealth & Remote Patient Monitoring Providers
Healthcare Call Centers & Nurse Triage Lines
Health Systems & Behavioral Health Clinics
Why it works
Language-agnostic acoustic analysis detects vocal micro-patterns regardless of primary dialect or topic.
API-first design seamlessly embeds mental health screening directly into existing clinical software workflows.
Proprietary dataset gathered across global users ensures diverse ML model validation and accuracy.
Founder story
Kintsugi was founded in 2019 in Berkeley, California, by Grace Chang and Rima Seiilova-Olson. Both founders experienced challenges accessing timely mental healthcare and recognized that objective screening tools were largely absent from primary care. As engineers, they treated behavioral screening as an infrastructure problem and developed AI algorithms capable of detecting signs of clinical depression and anxiety from subtle vocal nuances.
Alternatives
Comparison overview
Kintsugi analyzes non-contextual voice biomarkers rather than transcribing spoken speech content, whereas natural language tools depend on specific text keywords or responses.
Kintsugi delivers real-time screening scores via an API embedded in call center platforms like Pega, unlike standalone diagnostic apps requiring separate provider logins.